Additionally, activins display an antiproliferative effect in human breast cancer cells by arresting them in the G0/G1 cell cycle phase [5,6], an effect that may be counteracted by estrogen, since a crosstalk between activin and estrogen has been demonstrated [7]. This evidence concerns the gene INHBE and breast cancer.